In this experiment, administering PTP in C57BL/6J mice inhibited the abnormal increase in body weight, visceral obesity, and dyslipidemia induced by the HFD, and also enhanced insulin sensitivity, as shown by an insulin sensitivity test’s lower glucose levels and enhanced insulin tolerance. Here, INS is linked to metabolic syndrome.